Preparation of a working seed lot of BCG and quality control by PCR genotyping

Revista Argentina de Microbiologia

Volumn 42, Issue 1, 2010, Pages 4-10

  Trovero, A ^a   Arguelles C ^a   Cataldi, A ^b  

^a Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

^b INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

Author keywords

BCG strains; Genome; PCR; Quality control; Working seed lot

Indexed keywords

AMINOSALICYLIC ACID; BCG VACCINE; CARBOXYLIC ACID DERIVATIVE; CYCLOSERINE; ETHAMBUTOL; ISONIAZID; PHENOCARBOXYLIC ACID; RIFAMPICIN; STREPTOMYCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BACILLUS; BACTERIAL GENETICS; BACTERIAL STRAIN; CONTROLLED STUDY; GENOTYPE; MYCOBACTERIUM BOVIS; NONHUMAN; POLYMERASE CHAIN REACTION; QUALITY CONTROL;

ANIMALS; ANTIGENS, BACTERIAL; BCG VACCINE; BIOLOGICAL ASSAY; DNA, BACTERIAL; GENE DELETION; GENOME, BACTERIAL; GENOTYPE; GUINEA PIGS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; QUALITY CONTROL; SPECIES SPECIFICITY; VACCINES, ATTENUATED; VIRULENCE;

EID: 77951087648     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Andersen P, Doherty M. The success and failure of BCG implications for a novel tuberculosis vaccine. Nat Rev Microbiol 2005;3:656-61.
2. Baily GV. Tuberculosis prevention trial, Madras. Indian J Med Res 1980;72:1-74.
3. Bedwell J, Kairo S, Behr M, Bygraves J. Identification of substrains of BCG vaccine using multiplex PCR. Vaccine 2001;19:2146-51. (Pubitemid 32178365)
4. Behr MA. Correlation between BCG genomics and protective efficacy. Scand J Infec Dis 2001;33:249-52.
5. Behr MA, Small PM. A historical and molecular phylogeny of BCG strains. Vaccine 1999;17:915-22.
6. Behr MA, Wilson M, Gill W, Salamon H, Schoolnik G, Rane S, et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 1999;284:1520-3. (Pubitemid 129524431)
7. Bonifachich E, Chort M, Astigarraga A, Diaz N, Brunet B, Bottasso E. Protective effect of bacillus Calmette-Guérin (BCG) vaccination in children with extra-pulmonary to pulmonary disease A case-control study in Rosario, Argentina. Vaccine 2006;24:2894-9.
8. Brewer T. Preventing tuberculosis with bacillus Calmette-Guérin vaccine: a meta-analysis of literature. Clin Infect Dis 2000; 31: S64-7.
9. Brosch R, Gordon S, Garnier T, Eiglmeier K, Frigui W, Valenti P, et al. Genome plasticity of BCG and impact on vaccine efficacy. Proc Natl Acad Sci USA 2007;104:5596-601. (Pubitemid 47175726)
10. Brosch R, Gordon S, Marmiesse M, Brodin P, Buchrieser C, Eiglmeier K, et al. A new evolutionary scenario for My-cobacterium tuberculosis complex. Proc Natl Acad Sci USA 2002;99:3684-9. (Pubitemid 34252166)
11. Brosch R, Gordon S, Pym A, Eiglmeier K, Garnier T, Cole S. Comparative genomics of mycobacteria. Int J Med Microbiol 2000;290:143-52.
12. Colditz G, Brewer T, Berkey C, Wilson ME, Burdick E, Fineberg HV, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. JAMA 1994;271:698-702.
13. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998;393:537-43.
14. Dubos RJ, Pierce CH. Differential characteristics in vitro and in vivo of several substrains of BCG. Am Rev Tuberc Scand 1948;22:125-33.
15. Farmacopea Argentina. ANMAT, séptima edición. Argentina, 2002.
16. Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, et al. Whole-genome comparison of Myco-bacterium tuberculosis clinical and laboratory strains. J Bacteriol 2002;184:5479-90. (Pubitemid 35024395)
17. Garnier T, Eiglmeier K, Camus J, Medina N, Mansoor H, Pryor M, et al. The complete genome sequence of Mycobacterium bovis. Proc Natl Acad Sci USA 2003;100:7877-82. (Pubitemid 36760063)
18. Gordon S, Brosch R, Billault A, Garnier T, Eiglmeier K, Cole S. Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol Microbiol 1999;32:643-55. (Pubitemid 29233907)
19. Hsu T, Hingley-Wilson S, Chen B, Chen M, Dai A, Morin P, et al. The primary mechanism of attenuation of bacillus Calmette-Guérin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc Natl Acad Sci USA 2003;100:12420-5. (Pubitemid 37271575)
20. Lagranderie M, Balazuc A, Deriaud E, Leclerc C, Gheorghiui M. Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains. Infect Immun 1996;64:1-9. (Pubitemid 26009333)
21. Lewis K, Liao R, Guinn K, Hickey M, Smith S, Behr M, Sherman D. Deletion of RD1 from Mycobacterium tuberculosis mimics bacile Calmette-Guérin attenuation. J Infect Dis 2003;187:117-23. (Pubitemid 36034479)
22. Mahairas G, Sabo P, Hickey M, Singh D, Stover K. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 1996;178:1274-82. (Pubitemid 26073382)
23. Miceli I, Kantor I, Colaiacovo D, Peluffo G, Cutillo I, Gorra R, et al. Eficacia de la vacunación con BCG evaluada mediante el método de casos y testigos en Buenos Aires, Argentina. Bol Oficina Sanit Panam 1988;104:440-8.
24. Mostowy S, Tsolaki A, Small P, Behr M. The in vitro evolution of BCG. Vaccine 2003;21:4270-4.
25. Pym A, Brodin P, Brosch R, Huerre M, Cole S. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol Microbiol 2002;46:709-17. (Pubitemid 35365606)
26. Ritz N, Hanekom W, Robins-Browne R, Britton W, Curtis N. Influence of BCG vaccine strain on the immune response and protection against tuberculosis. FEMS Microbiol Rev 2008;32:821-41.
27. Sáenz A. Método de producción de vacuna BCG líquida de uso intradérmico Rev Argent Tuberc Enferm Pulm 1971;22:106-24.
28. Suter W, Dubos R. Variability of BCG strains (bacillus Calmette Guérin) J Exp Med 1951;93:559-72.
29. Van Soolingen D, Hermans P, Haas P, Soll D, Van Embden J. Occurrence and stability of insertion sequences in Myco-bacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J Clin Microbiol 1991;29:2578-86.
30. WHO Technical Report Series, No 745, 1987. Requirements for dried BCG vaccine. Geneva, Switzerland.
31. WHO Meeting Report. Consultation on the characterization of BCG strains. London, England, 15-16 December 2003.
32. WHO Report. Consultation on the characterization of BCG vaccines. Geneva, Switzerland, 8-9 December 2004.
33. WHO Report. Discussion on the improvement of quality control of BCG vaccines. Pasteur Institute, Paris, France, 7 June 2005.
34. Zhang Y, Wallace R, Mazurek G. Genetic differences between BCG substrains. Tuber Lung Dis 1995;76:43-50.